J&J’s McNeil Announces Further Recall on Tuesday
J&J’s McNeil Announces Further Recall on Tuesday

In the wake of the Congress probing the recall of liquid children’s Tylenol and other pediatric medicines by a Johnson & Johnson unit, the Company proclaimed on Tuesday that it has ordered the recall of another round of drugs which have already been supplied in the market.

McNeil Consumer Healthcare, the unit of Johnson & Johnson, which is under investigation, has directed the recall of Benadryl allergy tablets and one lot of Extra Strength Tylenol gel pills.

However, the officials refused to explain anything regarding the quantity of the medicines to be recalled.

“The products were inadvertently omitted from an earlier recall one preceding the children’s drug recall involving medicines made at a company plant in Puerto Rico”, said J&J.

Since November 2009, McNeil has witnessed the recall of nearly 11.7 million packs of Motrin products and around 6.3 million bottles of Tylenol Arthritis Pain caplets.

The first recall was ordered by the company when it acknowledged complaints about rotten smell coming out of some products.

It was later discovered by the FDA that the smell was the resultant of contamination of these products with a derivative of a material used for treating wooden transport pallets.

Latest News

Several popular apps making way to Windows 8
Nvidia to license graphics technology to other companies
AMD announces ‘Seattle’ microprocessor for server systems
First baby born using 'safer' IVF method
GM recalling 193,652 SUVs from model years 2006 and 2007
Microsoft Office will take time to become available on tablets
Ofsted-style ratings for hospitals
Google to reveal some details about its high-flying balloons
Strong competition between Microsoft and Sony is good for industry: EA
Alcohol-related disease patients deserve better care
U.S. Navy ditches ALL CAPS message format
Nokia to unveil 41MP camera-equipped Lumia EOS smartphone next month